AI zutere Bench: Ihe nlere anya imekọ ihe ọnụ AI CRO Peptide

Ọgụgụ isi nke okike agbanweela n'ụzọ bụ isi ọsọ nke nchọta ebumnuche na imewe mkpụrụ ndụ na sayensị ndụ. Ihe ama ama ama na mgbanwe a mere mgbe Insilico Medicine gosipụtara ike mmepụta ihe ndụ ya n'ebe nyocha ya., na-egosipụta ọgbọ mgbakọ na mwepụ nke ihe karịrị 5,000 Ndị na-achọ akwụkwọ peptide n'ime otu okirikiri imewe elekere 72 na-eji injin Biology42 ya. Nke a dị ịrịba ama arụmọrụ, anchored na Masdar City AI na ebe mgbakọ quantum, na-eme ka mgbanwe dị ukwuu na nchọpụta ọgwụ ọgbara ọhụrụ pụta ìhè: Ihe bụ isi mkpọ bụ agaghịkwa otú ngwa ngwa algọridim nwere ike isi mepụta usoro nhoputa ndi ochichi, mana ka ngwa ngwa kemistri anụ ahụ nwere ike ime ka ụlọ nyocha mmiri dị, sachaa, nyochaa, ma kwado amụma dijitalụ ndị ahụ.

Mgbe ụdị nrụpụta na-ewepụta puku kwuru puku FASTA usoro ma ọ bụ eriri SMILES na ụbọchị, nzukọ nyocha nkwekọrịta omenala (CRO) ụdị ịzụ ahịa na-akwụsị ngwa ngwa. Ọkọlọtọ 3- ka oge ngbanwe nke izu ise na-emepụta nnukwu ihe ndekọ azụ, na-eme ka pipeline mgbako dị oke ọnụ nọrọ ọdụ na-eche data njikọ anụ ahụ. Ọzọkwa, ntinye akwụkwọ ntuziaka, njikwa mma na-enweghị atụ (QC) akuko, na ihe arụrụ arụ physicochemical zoro ezo—dị ka acid trifluoroacetic fọdụrụnụ (TFA) cytotoxicity ma ọ bụ net peptide ọdịnaya misscalculation-webata mkpọtụ na-eweda igwe mmụta mmụta ihe nlereanya..

Iji weghara uru zuru oke nke generative biologics, biopharma R&Ndị isi D ga-eguzobe onye raara onwe ya nye Ụdị mmekorita AI CRO peptide. Usoro a na-arụ ọrụ na-eme ka ọdịiche dị n'etiti nnukwu ntinye na amụma silico na nkwado bench anụ ahụ site na usoro mgbanwe data ahaziri ahazi., SLAs na-agbanwe agbanwe, na stringent analytical njikwa njikwa.

The Generative Bottleneck: Ihe kpatara mpụta mgbakọ na mwepụ ji enweta nkwado anụ ahụ

Pipeline nchọpụta ọgwụ ọgbara ọhụrụ na-arụ ọrụ na-aga n'ihu Nhazi-Mepụta-Nnwale-mụta (DBTL) loop nzaghachi. Na nchoputa obere-molecule na peptide ọdịnala, usoro "Iwepụta" bụ oke-oke, chọrọ ọnwa nke ntuziaka ọgwụ chemistry imewe, mgbakọ n'ọdụ ụgbọ mmiri, na nhazi-mmekọrịta ọrụ (SAR) nkewa.

Generative AI tụgharịrị ike a. Ihe owuwu mmụta miri emi nke ọgbara ọhụrụ—gụnyere ụdị mgbasa ozi, Ụdị asụsụ protein dabere na transformer, na mkwado mmụta algọridim-nwere ike inyocha ọtụtụ ijeri ndị conformers mebere wee wepụta puku kwuru puku peptide kachasị mma n'ime awa.. Dị ka e gosiri na Insilico Medicine's generative biologics benchmarks, Igwe mgbakọ na mwepụ nwere ike nzacha ọba akwụkwọ mebere ruo n'ọkwa n'ọkwa dabere na mmekọ mmekọ amụma, solubility, na nkwụsi ike nke metabolic.

Ntugharị igodo: Ọkpụkpụ algọridim achịkọtala usoro “Ewepụta” site na ọnwa ruo awa. N'ihi ya, nzọụkwụ na-amachi ọnụego na nchọpụta peptide ọgwụgwọ agbanweela kpamkpam na interface "Build-Test"-kpọmkwem njikọ peptide siri ike nke anụ ahụ. (SPSS), mmiri mmiri-na-asachapụ, yana nkwado bioanalytical dị elu.

Agbanyeghị, molecule anụ ahụ ka na-ejide n'iwu nke kemịkalụ organic. Ịsụgharị usoro dijitalụ ka ọ bụrụ peptides anụ ahụ dị njikere nyocha na-ewebata ọtụtụ isi esemokwu dị egwu:

Mbupụta Synthesis na mgbagwoju anya: Ụdị AI na-emepụtakarị ihe mgbochi, nnukwu hydrophobic, ma ọ bụ beta-ibé akwụkwọ na-akpụ usoro peptide. Na-enweghị ezigbo akara ike nke sịntetik, Hits ndị a e buru n'amụma na-ata ahụhụ site na arụmọrụ njikọ dị ala na mkpokọta n'oge SPPS.
Ntugharị Latency: Ọ bụrụ na njikọ anụ ahụ na nyocha QC chọrọ 20 ka 30 ụbọchị azụmahịa, loop nzaghachi nzaghachi na-akụda. Ụdị AI enweghị ike imezigharị ọrụ akara ha na-enweghị ntinye mmụta na-arụ ọrụ n'oge site na nyocha anụ ahụ.
Usoro data na-akwụsị: Asambodo nyocha nke akwụkwọ ntuziaka PDF (CoAs) manye ndị sayensị ka ha jiri aka detuo mpaghara ịdị ọcha HPLC na ụkpụrụ spectrometry n'ime ọdụ data mgbakọ na mwepụ., iwebata njehie mmadụ na igbochi azụ azụ azụ ọkpọkọ akpaaka.

Ogidi ihe owuwu nke AI-ruo-Bench Framework CRO

Ịmepụta nke ọma na silico na mmiri mmiri nyocha peptide pipeline chọrọ iji usoro arụ ọrụ arụkọ ọrụ dochie usoro ịzụ ahịa ịzụ ahịa. Ihe nlereanya a dabere na ogidi isi atọ: igwe mgbanwe data enwere ike ịgụ, SLAs na-agbanwe agbanwe, yana nchekwa QC nyocha siri ike.

Ịkwụ ụgwọ mbata | NA-ebu ọnụ / NA-achị ọchị / Batch JSON v

Nchekwa physicochemical (Mgbanwe TFA-to-Acetate, Netwọk ọdịnaya, Ịgba nwa) Ịkwụ ụgwọ na-apụ apụ | Igwe-agụ CoA (JSON/CSV) Raw Spectral Data (mzml / Chromatogram) v

NA SILICO GENERATIVE ENGINE (Generative AI / Nchọpụta ebumnuche Onye nrụpụta Peptide akpọrọ / Akara molekụla) MKPỤTA Anụ ahụ & WET-LAB oche

Nkwekọrịta siri ike na-akpaghị aka (SPSS / Ngwakọta Microplate)
RP-HPLC Ọcha Ọcha & Nyochaa oke (HRMS / LC-MS) MMUTA NKE MMIRI emechiela (Nchacha ụdị akpaaka & Akara ọrụ mmekọ)

1. Atụmatụ mgbanwe data enwere ike ịgụ nke igwe-ahaziri

Iji kpochapụ ntinye data akwụkwọ ntuziaka na ịkwado njikọ nke roboti akpaghị aka, injin mgbako na ụlọ nyocha mmiri CRO ga-enwerịrị mkparịta ụka site na ahaziri ahazi, ugwo igwe-agụ.

Ịkwụ ụgwọ mbata (Mpụta mgbakọ → CRO Lab)

Mgbe engine generative na-ahọrọ otu ogbe nke peptides nwa akwukwo, ọ na-ebupụ faịlụ ntinye ahaziri ahazi (JSON ma ọ bụ CSV) nwere akwa data amanyere iwu atọ:

Ihe nchọpụta usoro & Nkọwapụta: Amino acid eke nọchiri anya otu mkpụrụedemede IUPAC/IUB; amino asịd na-abụghị canonical, cyclizations akụkụ-agbụ, ma ọ bụ mgbanwe ọnụ na-anọchi anya n'asụsụ Hierarchical Editing maka Macromolecules (HELM) ndetu.
Cheminformatics Structural: Canonical SILES ma ọ bụ ihe nnọchianya SDF, n'ịhụ na nhazi-maara njikwa nke d-amino acid, lipidations, ma ọ bụ njikọ PEG.
Amụma physicochemical: Ebe isoelectric buru amụma (pI), atụmatụ hydrophobicity index, na lekwasịrị anya ịdị ọcha (eg., crude screening vs. ≥95% njikarịcha ndu dị ọcha).

Ịkwụ ụgwọ na-apụ apụ (CRO Lab → Pipeline mmụta na-arụsi ọrụ ike)

Oligopeptides 41 Mgbe emechara njikọ anụ ahụ na nyocha nyocha, CRO na-ebupụ ngwugwu QC ahaziri ahazi ozugbo na ọdọ data igwe ojii ma ọ bụ LIMS site na API:

Igwe-agụ CoA (JSON/CSV): Nwere ID batch, gbakọọ monoisotopic uka, oke-na-ụcha ego hụrụ (m/z), RP-HPLC pasentị ịdị ọcha kacha elu, pasent ọdịnaya peptide net, nchọpụta nnu fọdụrụnụ, na ọkwa endotoxin.
Faịlụ Spectral Raw: Igwe data raw data nwere ike ịgụ, gụnyere faịlụ usoro mzML maka nnukwu spectrometry na ASCII/CSV raw chromatographic traces maka HPLC.

2. Ihe nrịbama SLA dị elu maka nchịkọta Peptide dị elu

Usoro ndụ dị iche iche nke nchọpụta ọgwụ na-achọ nha nha ọsọ dị iche iche, ịdị ọcha, na ọnụọgụgụ. Ịkwanye otu ≥98% ịdị ọcha chọrọ na nyocha mmalite Ụlọ ọrụ na-emepụta Peptide arrays na-egbu oge na ego. N'aka nke ọzọ, iji peptides crude na nyocha nke sitere na cell na-etinye ihe egwu dị elu dị elu nke adịchaghị mma na nke adịgboroja n'ihi adịghị ọcha n'usoro nke mpịachi..

Acetyl Hexapeptide 38 Nke kachasị njikọ SLA nke peptide dị elu framework na-arụ ọrụ n'ofe ọkwa ọrụ atọ dị iche iche:

Ọkwa 1: Usoro nyocha dị elu (Ngwa ngwa ngwa DBTL)

Ọnụ ọgụgụ: 1 mg na 5 mg kwa usoro na 96-well ma ọ bụ 384-nke ọma array formats.
Ebumnuche dị ọcha: Chọde ka >85% ịdị ọcha.
Ngbanwe SLA: 5 ka 7 ụbọchị azụmahịa.
Ngwa nke izizi: Nlebanya njikọ njikọ nke mbụ site na iji Resonance Plasmon Surface (SPR), Interferometry bio-Layer (GỤỌ), ma ọ bụ Fluorescence Polarization (FP). Na-enyocha puku kwuru puku AI ngwa ngwa ruo n'ọkwa dị elu.

Ọkwa 2: Nbulite ndu & Pịa Re-Synthesis

Ọnụ ọgụgụ: 5 mg na 25 mg.
Ebumnuche dị ọcha: ≥95% ezipụta ịdị ọcha site na Reverse-Phase HPLC.
Ngbanwe SLA: 10 ka 12 ụbọchị azụmahịa.
Ngwa nke izizi: Bioassay ọrụ nke abụọ (Mkpebi EC50/IC50), nnwale nkwụsi ike plasma, na nyocha nke metabolism metabolism.

Ọkwa 3: Ọnụ ọgụgụ nke preclinical & Mgbanwe

Ọnụ ọgụgụ: 100 mg ka multigram quantities.
Ebumnuche dị ọcha: ≥98% ezipụta ịdị ọcha na mgbanwe counterion zuru oke.
Ngbanwe SLA: 15 ka 20 ụbọchị azụmahịa.
Ngwa nke izizi: Na vivo pharmacokinetics (PK/PD), toxicology anụmanụ, na IND na-enyere aka ọmụmụ ihe izizi.

Maka ndụmọdụ: Mgbe ị na-ekwurịta nkwekọrịta CRO maka ọrụ AI na-emepụta ihe, guzobe ntughari SLAs ejiri n'aka nke jikọtara ya na nhazi usoro akpaaka karịa iwu otu usoro.. Mmekọrịta ya na ndị na-enye ndị ọkachamara dị ka MOL mgbanwe, nke na-arụ ọrụ nhazi usoro nhazi usoro siri ike na klaasị 100 gburugburu ụlọ dị ọcha, na-eme ka ogbugbu dị ngwa ngwa na-emebighị nguzobe ogbe-na-ogbe.

3. Nyocha QC & Nchekwa physicochemical

Na nchọpụta ọgwụ algorithmic, data nnwale na-eme mkpọtụ ma ọ bụ ezighi ezi bụ ọdachi: ọ na-emegharị ụdị mmepụta na echiche ụgha, skewing ọdịnihu nwa akwukwo amụma. Iji hụ na ntinye mmụta na-arụsi ọrụ ike dị elu, nkwado CRO nke anụ ahụ ga-emerịrị ebe nyocha nyocha anọ siri ike.

Mass & Nnwale njirimara (HRMS / LC-MS/MS)

Ogbe ọ bụla emepụtara ga-enwerịrị spectrometry mass spectrometry dị elu (ESI-TOF ma ọ bụ MALDI-TOF) iji kwado ịdị arọ molekụla monoisotopic megide ihe owuwu molekụla buru amụma. Maka usoro mgbagwoju anya nwere àkwà mmiri disulfide ma ọ bụ amino acid isobaric, tandem LC-MS/MS nyocha iberi na-enyocha njikọ ziri ezi na nhazi usoro.

Ntụle ịdị ọcha (RP-HPLC)

A ga-enyocha ịdị ọcha site na iji Chromatography Liquid Liquid-Phase High- Performance (RP-HPLC) ya na kọlụm silica C18 ma ọ bụ C4 kachasị na trifluoroacetic acid (TFA) / acetonitrile gradients. Njikọ nke ultraviolet (UV) absorption traces na 214 nm na 254 nm na-eme ka nchọpụta ziri ezi nke absorption nke ọkpụkpụ azụ peptide na ụdọ akụkụ aromatic.

Mgbanwe mgbanwe TFA-to-Acetate

Ngwakọta peptide siri ike na-eji TFA n'oge mgbawa resin yana sachaa HPLC. N'ihi ya, A na-ebufe peptides omenala dị ka nnu trifluoroacetate.

Agbanyeghị, TFA fọdụrụnụ nwere ike imegide sel ndị dị ndụ: Ntinye uche TFA dị obere ka 0.01% nwere ike ịkpata mmebi nke akpụkpọ ahụ cell na ọnwụ cell na nyocha ọrụ, na-eduga n'oke nsi na-egbu egbu ụgha na-agụ.

⚠️ Ịdọ aka ná ntị: Ewebatala peptides nnu TFA raw ozugbo n'ime nyocha ọrụ dabere na cell. Maka ọkwa niile 2 na Tier 3 ọmụmụ nkwado, manye iwu mgbanwe mgbanwe site na trifluoroacetate ruo acetate ma ọ bụ chloride salts iji gbochie ihe ndị na-egbu egbu cell..

Mkpebi ọdịnaya Peptide Net

Lyophilized peptide ntụ ntụ abụghị 100% protein peptide dị ọcha. Ọ nwere mgbochi mgbochi, Chọpụta ihe mgbaze organic, na etinye obi gị dum mmiri. Nke n'ezie net peptide ọdịnaya na-adịkarị n'etiti 65% na 85% nke ngụkọta akọrọ arọ.

Ọ bụrụ na protocol nyocha na-akpọ maka ịkwadebe a 10 MM ngwaahịa ngwaahịa dabere na oke oke akọrọ, A ga-eleda mkpokọta peptide n'ezie anya site na 15% ka 35%. Njehie itinye uche a na-agbagọ kinetics jikọtara ọnụ (Kd) na ike ọrụ (EC50). Ngwunye CRO na-akwado nkwado AI ga-akọrịrị ọdịnaya peptide net nke akọwapụtara nke ọma site na nyocha nitrogen elemental (CHN) ma ọ bụ nyocha nke amino acid (AAA).

Ịrụ ọrụ Nlebanya emechi-emechi

Ebumnuche kacha nke a nchọpụta peptide DBTL mechiri emechi usoro bụ mmụta na-arụsi ọrụ ike: na-eji nsonaazụ nnwale anụ ahụ na-aga n'ihu na-emelite algọridim na-emepụta akara.

Gbanwee ihe na-ejikọta kinetic (Kd) dabere na ezi net peptide arọ v

AMAOKWU WET-LAB QC data anụ ahụ

Nyocha HRMS Monoisotopic Mass
Profaịlụ ịdị ọcha Chromatographic RP-HPLC
Solubilization tụrụ atụ & Ọdịnaya Peptide Net % MMEHIE OKWU AKA & NKWUO
Wepu ihe na-adịghị mma nke TFA cytotoxicity AI MODEL RETRAINING fọdụrụnụ kpatara & IHE NDỊ KWESỊRỊ IHE
Melite ọrụ nrịba ohere ịnweta sịntetik
Mechaa okirikiri ike usoro-na-slubility

Mgbe data CRO anụ ahụ na-alaghachi azụ na ọkpọkọ mgbakọ, Ederede nleba anya mperi akpaaka ga-enyocharịrị dataset tupu nzụghachi ihe nlereanya emee: Anyị na-azụ 290

Ọdịmma sịntetik Re-weighting: Ọ bụrụ kpọmkwem usoro motifs (eg., hydrophobic trimers ugboro ugboro ma ọ bụ poly-glutamine na-agbatị) na-adaba njikọ ma ọ bụ mkpụrụ <10% crude ịdị ọcha, ihe nlereanya AI na-akpaghị aka na-abawanye akara ntaramahụhụ maka usoro sịntetik ndị ahụ na okirikiri imewe n'ọdịnihu.
Solubility & Nhazi nhazi: A na-esetịpụ metrik solubility anụ ahụ a na-ahụ n'oge nhazigharị megide oke lipophilicity buru amụma (LogP/LogD), na-emezigharị ụdị amụma ihe onwunwe biophysical AI.
Assay Normalization: A na-atụba ihe ngbanwe nke kinetic sitere na SPR/BLI na-akpaghị aka site na iji ụkpụrụ ọdịnaya peptide ụgbụ a tụrụ atụ, n'ịhụ na ụdị akara akara mmekọrịta na-azụ na mkpokọta molekụla.

Ntụle mmetụta arụ ọrụ: Ntugharị site na iwu azụmahịa CRO ọdịnala gaa na usoro DBTL mechiri emechi na-ewepụta uru arụmọrụ enwere ike gafee biopharma R&D pipeline:

50% Mbelata na Oge okirikiri DBTL: Ngwakọta nhazi ngwa ngwa akpaaka na-ebelata ngbanwe nke anụ ahụ site na 4 izu ruo 5-7 ụbọchị azụmahịa.

60% Mmụba na arụmọrụ mmụta na-arụsi ọrụ ike: Ntinye QC nke igwe a na-agụ akpaghị aka na-ewepụ mgbochi ntinye ntinye data na njehie ndegharị mmadụ..

35% Nlereanya akara kacha elu: Ịmezi ejikọta data megide ezi ọdịnaya peptide net yana iwepụ ụda cytotoxicity TFA na-eme ka amụma mmekọrịta dị mma..

SLA arụ ọrụ & QC Benchmark Matrix maka AI Peptide Projects

Iji duzie ịzụ ahịa na R&D ime mkpebi, Matriks na-esonụ na-akọwapụta nkọwa arụmọrụ ọkọlọtọ n'ofe isi mmalite nke ọrụ nchọpụta peptide nke AI na-achụ.:

Oge nchọpụta	Oke Oke	Ebumnuche Dị Ọcha kacha	Ngbanwe SLA	Ngwungwu QC amanyere iwu	Ngwa Bioassay Primary
Ọkwa 1: Usoro nyocha	1 mg - 5 mg	Chọde ka >85%	5-7 ụbọchị azụmahịa	LC-MS njirimara, Usoro RP-HPLC, Map usoro nke JSON	Ngwakọta agbakwunyere dị elu (SPR, GỤỌ, FP)
Ọkwa 2: Nbulite ndu	5 mg - 25 mg	≥95% kwadoro	10-12 ụbọchị azụmahịa	HRMS, RP-HPLC UV214/254, Ọdịnaya Peptide Net %	Nyocha arụmọrụ dabere na cell nke abụọ (EC_{50}/IC_{50})
Ọkwa 3: Ọnụ ọgụgụ nke preclinical	100 mg - Multi-gram	≥98% kwadoro	15-20 ụbọchị azụmahịa	HRMS, RP-HPLC, Mgbanwe TFA-to-Acetate, LAL Endotoxin (<0.1 EU/mg)	Na Vivo PK/PD, Toxicology, Nkwado IND nke preclinical

Atụmatụ usoro mmejuputa atumatu maka Biopharma R&D Ndị isi

Na-ewu ihe agile, Akụrụngwa nkwado CRO dị njikere AI chọrọ nhazi usoro n'ofe mgbakọ, mmiri-ụlọ nyocha, na otu ịzụ ahịa. Biopharma R&Ndị isi D kwesịrị ime usoro ụzọ mmejuputa iwu nke nzọụkwụ atọ:

Hazie interface ingestion: Ntugharị usoro mgbakọ na mwepụ dị n'ime site na mbupụ akwụkwọ mgbasa ozi rụrụ arụ gaa na-ebupụta ibu JSON/HELM kwadoro.. Mepụta ebe ngwụcha API igwe ojii maka ịnata ngwungwu nyocha CRO nwere ike ịgụ.
Mepụta SLAs n'ịzụ ahịa: Si na isi ike pụọ, nkwekọrịta ndị na-ere otu-adị ọcha. Nkwekọrịta ọrụ nna ukwu n'usoro (Ndị MSA) nke gụnyere Tier 1 nhọrọ ntụgharị ngwa ngwa ụbọchị 5 maka nyocha mbụ.
Onye mmekọ ya na CROs pụrụiche dị oke ọcha: Họrọ ndị mmekọ nke nwere ngwa SPPS akpaaka ọgbara ọhụrụ, Klas 100 gburugburu mmepụta ihe na-adịghị mma, yana Pọtụfoliyo mgbanwe siri ike (eg., ịgba ígwè, amino acid na-ekwekọghị n'okike, njikọ nke lipid).

Site n'iji nhazi data mechiri emechi na ogbugbu anụ ahụ a pụrụ ịdabere na ya dochie usoro ọrụ ntuziaka gbasasịrị., Ndị otu biopharma nwere ike mezuo nkwa nke AI na-emepe emepe-ịtụgharị amụma usoro dijitalụ ka ọ bụrụ ndị na-aga ụlọ ọgwụ akwadoro na ọsọ a na-enwetụbeghị ụdị ya..

Banyere Onye dere ya

Ọ bụ ndị dere ụkpụrụ a MOL na-agbanwe Peptide R&D Otu, otu ndị ọkachamara na-ahụ maka ọgwụ ọgwụ, ndị injinia bioprocess, na ndị ọkà mmụta sayensị bioanalytical raara onwe ha nye ịkwalite ịdị ọcha dị elu, Ngwakọta peptide akpaghị aka na imepụta ihe na-adịghị mma maka nyocha biopharma dị oke ọnụ.

Nzọụkwụ ọzọ maka pipeline nchọpụta Peptide gị

Na-enyocha ndị mmekọ ahaziri iche iji kwado usoro nchọta AI na-akwalite gị? Nyochaa MOL na-agbanwe usoro nhazi peptide omenala ịmụta ka klas anyị 100 ụlọ ọcha, 300+ arụmọrụ mgbanwe ike, na ntụgharị ngwa ngwa SLA nwere ike mee ka nkwenye gị dị ngwa ngwa. Caprooyl Tetrapeptide 3

Bingyan Gao

Ọkachamara na nyocha nyocha Ọkachamara isi: Nkewa na njirimara nke adịghị ọcha, Mmepe usoro HPLC/MS, chiral ịdị ọcha analysis, yana nrube isi na mba ụwa pharmacopoeias.

Profaịlụ: Bingyan Gao bụ "onye nche ọnụ ụzọ ámá" nke ịdị ọcha na ịdị mma peptide. Ọ maara nke ọma n'iji ngwa nyocha dị elu dị iche iche na ọkachamara n'ịzụlite ụzọ nkewa chromatographic ahaziri maka peptides gbanwetụrụ nke ukwuu.. O guzobela usoro profaịlụ adịghị ọcha siri ike nke na-abụghị naanị na-eme ka ngwaahịa dị ọcha nke 99% ma ọ bụ karịa mana ọ na-achọpụtakwa kpọmkwem ma kpochapụ adịghị ọcha nke nwere ike ịkpata immunogenicity. Site na nghota miri emi nke iwu FDA na EMA chọrọ maka ọgwụ peptide, ọ na-ahụ na ogbe ọ bụla ewepụtara na ụlọ ọrụ ahụ na-esonyere ya na Asambodo nyocha zuru oke na ikike. (COA).

Ngwaahịa

Akụkọ